Landmark Literature 2024-2025, Part 1
May 23, 2025
Andrzej Grzybowski outlines the advances in ophthalmology research over the last 12 months
7 min read
False
Welcome to The Ophthalmologist June 2025! In this issue, Power Lister Andrzej Grzybowski reviews the key ophthalmology research of the last 12 months for our Landmark Literature feature; Caroline Watson discusses how surgeons can expand access to interventional glaucoma treatment; and Andrea Tooley, Associate Professor of Oculoplastic and Orbital Surgery and Ophthalmology Residency Program Director at Mayo Clinic, looks back at how mentorship, motherhood, and molecular science have shaped her career so far.
May 23, 2025
Andrzej Grzybowski outlines the advances in ophthalmology research over the last 12 months
7 min read
April 28, 2025
Our 2025 Power Listers explore the major trends in their field, and the seismic impact AI and machine learning is having on the profession
4 min read
April 22, 2025
Peptide-based eye drops show promise as RP treatment, slowing photoreceptor degeneration in animal models
3 min read
April 22, 2025
Some thoughts on the evolving world of interventional glaucoma
4 min read
April 2, 2025
Michael Mikhail details his lessons learned from managing complex trauma cases in low-income settings
6 min read
March 30, 2025
Study sheds light on the quality-of-life impact of dry eye disease
2 min read
March 17, 2025
Improving outcomes and easing patient burden with SLT, extended-release implants, and MIGS
6 min read
February 25, 2025
Five exit strategies every eye surgery practice owner should know
5 min read
February 3, 2025
Strategies for managing that scarcest of all resources – time – to keep your retina practice on the cutting-edge
7 min read
January 24, 2025
A standardized way to evaluate IOLs based on clinical outcomes that matter to patients
5 min read
January 20, 2025
Sitting Down With… Andrea Tooley, Associate Professor of Oculoplastic and Orbital Surgery and Ophthalmology Residency Program Director at Mayo Clinic, Rochester, Minnesota, USA
5 min read
January 8, 2025
How PRESERFLO™ MicroShunt continues to prove its effectiveness and longevity in a crowded market
7 min read
False
False
False
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: